Bristol-Myers Squibb Co.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2021
Total Assets: $109.31B
Liabilities Breakdown FY2021
Total Liabilities: $73.31B
Asset Breakdown
Total Assets: $109.31B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $13.98B | 12.8% |
| Accounts Receivable | $7.98B | 7.3% |
| Inventory | $2.10B | 1.9% |
| Property, Plant & Equipment | $6.05B | 5.5% |
| Goodwill | $20.50B | 18.8% |
| Intangible Assets | $42.53B | 38.9% |
| Other Assets | $16.18B | 14.8% |
Liabilities Breakdown
Total Liabilities: $73.31B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.95B | 4.0% |
| Long-Term Debt | $39.61B | 54.0% |
| Other Liabilities | $30.75B | 42.0% |